Over this period, the number of initiators gradually decreased from 0.031% in 2009 to 0.017% in 2020, indicating a decreasing trend in hydroxychloroquine initiators, particularly those with rheumatoid arthritis (eTable 2 in Supplement 1 ).
← all excerpts
Practice Patterns of Screening for Hydroxychloroquine Retinopathy in South Korea.
1
—
—